Neo Ivy Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,002
| Closed | -$726K | – | 312 |
|
|
2024
Q3 | $726K | Buy |
+11,002
| New | +$726K | 0.24% | 159 |
|
|
2022
Q4 | – | Sell |
-695
| Closed | -$57K | – | 401 |
|
|
2022
Q3 | $57K | Buy |
+695
| New | +$57K | 0.15% | 211 |
|
|
2022
Q2 | – | Sell |
-3,780
| Closed | -$444K | – | 468 |
|
|
2022
Q1 | $444K | Buy |
3,780
+1,669
| +79% | +$196K | 0.4% | 85 |
|
|
2021
Q4 | $273K | Sell |
2,111
-5,695
| -73% | -$736K | 0.39% | 97 |
|
|
2021
Q3 | $539K | Buy |
+7,806
| New | +$539K | 0.62% | 39 |
|
|
2021
Q1 | – | Sell |
-1,421
| Closed | -$130K | – | 513 |
|
|
2020
Q4 | $130K | Sell |
1,421
-762
| -35% | -$69.7K | 0.14% | 216 |
|
|
2020
Q3 | $174K | Sell |
2,183
-5,623
| -72% | -$448K | 0.18% | 211 |
|
|
2020
Q2 | $539K | Buy |
7,806
+2,571
| +49% | +$178K | 0.62% | 39 |
|
|
2020
Q1 | $329K | Sell |
5,235
-3,795
| -42% | -$239K | 0.54% | 41 |
|
|
2019
Q4 | $702K | Buy |
+9,030
| New | +$702K | 0.81% | 12 |
|